nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—Enterocolitis—Varenicline—nicotine dependence	0.146	0.158	CcSEcCtD
Ceftriaxone—Fungal infection—Varenicline—nicotine dependence	0.0526	0.0567	CcSEcCtD
Ceftriaxone—Nephrolithiasis—Varenicline—nicotine dependence	0.0505	0.0545	CcSEcCtD
Ceftriaxone—Glycosuria—Varenicline—nicotine dependence	0.0501	0.054	CcSEcCtD
Ceftriaxone—Tenderness—Varenicline—nicotine dependence	0.0465	0.0502	CcSEcCtD
Ceftriaxone—Leukocytosis—Varenicline—nicotine dependence	0.0432	0.0466	CcSEcCtD
Ceftriaxone—Hypertonia—Varenicline—nicotine dependence	0.0356	0.0384	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Varenicline—nicotine dependence	0.0269	0.029	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.0225	0.0243	CcSEcCtD
Ceftriaxone—Stomatitis—Varenicline—nicotine dependence	0.0221	0.0239	CcSEcCtD
Ceftriaxone—Epistaxis—Varenicline—nicotine dependence	0.0214	0.0231	CcSEcCtD
Ceftriaxone—Erythema multiforme—Varenicline—nicotine dependence	0.0193	0.0208	CcSEcCtD
Ceftriaxone—Chills—Varenicline—nicotine dependence	0.0183	0.0197	CcSEcCtD
Ceftriaxone—Flatulence—Varenicline—nicotine dependence	0.0175	0.0189	CcSEcCtD
Ceftriaxone—Dysgeusia—Varenicline—nicotine dependence	0.0174	0.0187	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Varenicline—nicotine dependence	0.0165	0.0178	CcSEcCtD
Ceftriaxone—Anaemia—Varenicline—nicotine dependence	0.0164	0.0177	CcSEcCtD
Ceftriaxone—Agitation—Varenicline—nicotine dependence	0.0163	0.0176	CcSEcCtD
Ceftriaxone—Malaise—Varenicline—nicotine dependence	0.016	0.0173	CcSEcCtD
Ceftriaxone—Palpitations—Varenicline—nicotine dependence	0.0157	0.0169	CcSEcCtD
Ceftriaxone—Convulsion—Varenicline—nicotine dependence	0.0154	0.0166	CcSEcCtD
Ceftriaxone—Discomfort—Varenicline—nicotine dependence	0.0149	0.0161	CcSEcCtD
Ceftriaxone—Oedema—Varenicline—nicotine dependence	0.0145	0.0156	CcSEcCtD
Ceftriaxone—Infection—Varenicline—nicotine dependence	0.0144	0.0155	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Varenicline—nicotine dependence	0.0142	0.0153	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Varenicline—nicotine dependence	0.014	0.0151	CcSEcCtD
Ceftriaxone—Dyspepsia—Varenicline—nicotine dependence	0.0127	0.0138	CcSEcCtD
Ceftriaxone—Pain—Varenicline—nicotine dependence	0.0124	0.0134	CcSEcCtD
Ceftriaxone—Feeling abnormal—Varenicline—nicotine dependence	0.0119	0.0129	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Varenicline—nicotine dependence	0.0118	0.0128	CcSEcCtD
Ceftriaxone—Urticaria—Varenicline—nicotine dependence	0.0115	0.0124	CcSEcCtD
Ceftriaxone—Abdominal pain—Varenicline—nicotine dependence	0.0114	0.0123	CcSEcCtD
Ceftriaxone—Body temperature increased—Varenicline—nicotine dependence	0.0114	0.0123	CcSEcCtD
Ceftriaxone—Hypersensitivity—Varenicline—nicotine dependence	0.0107	0.0115	CcSEcCtD
Ceftriaxone—Pruritus—Varenicline—nicotine dependence	0.0102	0.0111	CcSEcCtD
Ceftriaxone—Diarrhoea—Varenicline—nicotine dependence	0.00991	0.0107	CcSEcCtD
Ceftriaxone—Dizziness—Varenicline—nicotine dependence	0.00958	0.0103	CcSEcCtD
Ceftriaxone—Vomiting—Varenicline—nicotine dependence	0.00921	0.00993	CcSEcCtD
Ceftriaxone—Rash—Varenicline—nicotine dependence	0.00913	0.00985	CcSEcCtD
Ceftriaxone—Dermatitis—Varenicline—nicotine dependence	0.00912	0.00984	CcSEcCtD
Ceftriaxone—Headache—Varenicline—nicotine dependence	0.00907	0.00979	CcSEcCtD
Ceftriaxone—Nausea—Varenicline—nicotine dependence	0.0086	0.00928	CcSEcCtD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00727	0.0996	CbGpPWpGaD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0069	0.0945	CbGpPWpGaD
Ceftriaxone—GLUL—Neuronal System—CHRNB3—nicotine dependence	0.00557	0.0763	CbGpPWpGaD
Ceftriaxone—GLUL—Neuronal System—CHRNA6—nicotine dependence	0.00528	0.0724	CbGpPWpGaD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00499	0.0683	CbGpPWpGaD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00478	0.0655	CbGpPWpGaD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00444	0.0609	CbGpPWpGaD
Ceftriaxone—GLUL—Neuronal System—GABRA4—nicotine dependence	0.00382	0.0523	CbGpPWpGaD
Ceftriaxone—GLUL—Neuronal System—CHRNB4—nicotine dependence	0.00366	0.0502	CbGpPWpGaD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00362	0.0496	CbGpPWpGaD
Ceftriaxone—GLUL—Neuronal System—CHRNA5—nicotine dependence	0.0034	0.0466	CbGpPWpGaD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00319	0.0437	CbGpPWpGaD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.0029	0.0397	CbGpPWpGaD
Ceftriaxone—GLUL—Neuronal System—CHRNA3—nicotine dependence	0.00278	0.038	CbGpPWpGaD
Ceftriaxone—GLUL—Neuronal System—CHRNB2—nicotine dependence	0.00244	0.0335	CbGpPWpGaD
Ceftriaxone—GLUL—Neuronal System—CHRNA4—nicotine dependence	0.00222	0.0304	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00102	0.014	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CYP2A7—nicotine dependence	0.000962	0.0132	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000945	0.0129	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000877	0.012	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00078	0.0107	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000651	0.00892	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000338	0.00464	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP2A7—nicotine dependence	0.000159	0.00217	CbGpPWpGaD
